
The landscape of Medicare Advantage (MA) has shifted. While many plans are still operating under the "find every code" mentality of 2015, the regulatory environment has undergone a seismic transformation.
With the 2023 RADV Final Rule and the 2027 Advance Notice, the Centers for Medicare & Medicaid Services (CMS) has moved from passive oversight to aggressive, data-driven enforcement. The question for MA plans is no longer if they will be audited, but whether their operations can withstand the scrutiny without grinding to a halt.
The change isn't just in the rules; it’s in the sheer scale of enforcement. In past years, CMS audited roughly 60 plans annually. Now, the agency is scaling to audit all 550+ eligible contracts every year.
To fuel this engine, CMS has hired 2,000 new coders, signaling a move toward a permanent, industrial-scale audit cycle. However, the real "teeth" of this new era are extrapolation.
Translation: A 5% error rate in a small sample could result in a multi-million dollar clawback that hits the financials of health plans with the force of a tidal wave.
The CMS 2027 Advance Notice (currently in the comment phase through February 25, 2026) has drawn a line in the sand regarding "unlinked" chart reviews.
For years, many plans relied on vendors to "mine" old medical records for diagnosis codes that were never part of an actual claim or doctor’s visit. In some cases, plans were reportedly reviewing the same charts up to five times, desperate to find an extra HCC (Hierarchical Condition Category) code to boost revenue.
CMS’s new stance is clear: No visit, no payment. If a diagnosis wasn't documented during a face-to-face encounter where care was actually delivered, it is no longer a valid source of truth. This moves the industry away from "finding codes" and toward "documenting care."
The 2026 HealthEdge report highlights a jarring statistic: 85% of health plan executives say regulatory pressure is now hitting their bottom line. The reason? Most plans have a "Validation Gap."
Plans have spent millions building "finding" machines: tools and vendors that identify potential codes. But very few have built "cleaning" machines.
The plans that will survive the 2027 transition are those that stop treating risk adjustment as a "look-back" exercise. Instead, they are moving the validation to the point of care.
Instead of a vendor reviewing a chart six months after a patient visit, modern plans use integrated clinical data (EHR, pharmacy, and claims) to surface gaps to the physician during the visit.
If you want to protect your margins and stay audit-ready without grinding your operations to a halt, you must prioritize these three capabilities:
The comment period for the 2027 changes ends on February 25, 2026, with final rates coming on April 6. While some industry groups are fighting the changes, the direction of the tide is unmistakable.
The future of Medicare Advantage belongs to plans that get paid for managing conditions, not just discovering them in paperwork. It’s a shift from "volume" to "value," and while the transition is painful, it ultimately leads to a more sustainable, care-focused industry.
The plans that embrace this now won't just survive the next audit; they will lead the market.
Move Forward with Galaxy. Request a demo to see how Galaxy can improve your ratings while reducing the manual work that currently limits your teams.
Also Read: How Risk Adjustment Software Improve Coding Accuracy.